John C. Lipman - 23 Oct 2025 SCHEDULE 13G Report for ENDRA Life Sciences Inc. Common Stock, par value $0.0001 (NDRA)

Filing Manager
John C. Lipman
Reporting Manager
John Carter Lipman
Security
ENDRA Life Sciences Inc. Common Stock, par value $0.0001
Symbol
NDRA
Shares outstanding
1,155,926 shares
Disclosed Ownership
115,477 shares
Ownership
10%
Form type
SCHEDULE 13G
Filing time
30 Oct 2025, 09:05:16 UTC
Date of event
23 Oct 2025
SEC
View on sec.gov

Quoteable Key Fact

"John C. Lipman disclosed 10% ownership in ENDRA Life Sciences Inc. Common Stock, par value $0.0001 (NDRA) on 23 Oct 2025."

Quick Takeaways

  • John C. Lipman filed SCHEDULE 13G for ENDRA Life Sciences Inc. Common Stock, par value $0.0001 (NDRA).
  • Disclosed ownership: 10%.
  • Date of event: 23 Oct 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 30 Oct 2025, 09:05.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
John Carter Lipman 10% 115,477 115,477 0 /s/ John Carter Lipman John Carter Lipman